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Prom the time when the lupus erythematosus 
cell was first described by Hargraves, Richmond, 
and Morton1 there has been much speculation as to 
what factors are responsible for its production. 
Initially it v/as believed that the L.E. cell was 
was pathognomonic of lupus erythematosus. As the 
phenomenon became better known, however, various 
workers reported the L.E. cell phenomenon in other 
diseases ,’<:) 
Early investigators of the L.E. cell hypothe¬ 
sized that the phenomenon was due to a factor pres¬ 
ent in the blood plasma. This theory was later 
borne out by experiments which demonstrated that 
the L.E. factor was present in the gamma globulin 
r-i 
fraction of the plasma proteins.1 
Miescher has demonstrated that absorption of 
lupus serum with isolated nuclei results in removal 
A 
or destruction of the L.E. factor. Very recently 
the fluorescent antibody technique has been applied 
to this problem. In the first report of such studies 
it was shown in vitro that a globulin factor of 
lupus serum adheres to nuclei in sections of tissue, 
Further studies revealed that nucleoprotein might 
be the nuclear factor involved in this reaction. ' 
The investigation to be reported here is an attempt 
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to further elucidate this problem through the use 




The L.B. Cell 
The L.B. cell was first described by Hargraves, 
Richmond, and Morton in 194-8* They often noted that 
in the bone marrow of patients with lupus erythema¬ 
tosus a peculiar cell was to be found. ’’This cell 
undoubtedly represents a process which is going on 
in such bone marrows and is the end result of one 
of two things: either phagocytoses of free nuclear 
material with a resulting round vacuole containing 
this partially digested and lysed nuclear material 
or, second, an actual autolysis of one or more lobes 
of the nucleus of the involved cell so that it pre¬ 
sents essentially the same appearance as the one 
which has phagocytized nuclear material.Hargraves, 
Richmond, and Morton concluded their description of 
the L.E. cell by suggesting that the finding of L.E. 
cells in a patients’ bone marrow might be of some 
help in diagnosing lupus erythematosis. Shortly 
after the publication of the original description 
other workers reported finding such cells in patients 
with systemic lupus erythematosis. A-L 
For a time it was believed that these peculiar 
cells were pathognomonic of disseminated lupus 
erythematosis. ° Later investigations, however, 
demonstrated that this was not true. L.E. cells 
have been found in association with the ”collagen 





3x1 cd-lias i f 
s.. 
. 
. . . - 
. 
, j jjc l O'. ih ' 
. 
. . 
ns so’ ev&d 
!}-♦ 
as well. In particular, L.E. cells have been 
D I, 
described in periarteritis nodosa,-' penicillin’ 
and hydantoin- hypersensitivity, as well as during 
hydralazine therapy,0 
The L.E, Cell Phenomenon 
Until 19^9 the only reliable way in which L.E. 
cells could be demonstrated was by aspiration and 
examination of bone marrow. If the bone marrow was 
hypoplastic or the patient too ill for sternal 
puncture this method of investigation had obvious 
disadvantages. In I9I1.9 Haserick and Bortz found 
that L.E. cells could be produced by adding plasma 
taken from patients "with acute disseminated lupus 
erythematosis to heparinized normal bone marrow.^-2,13 
It was also noted that leukocyte clumping was induced. 
The discovery of the L.E. cell phenomenon was 
very important because it shed light on a few basic 
principles concerning the L.E. cell. First of all, 
it revealed that the plasma of patients with acute 
disseminated lupus erythematosus contained a factor 
responsible for the formation of the L.E. cell. 
Secondly, it also became apparent that the production 
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The L.E. Cell Factor 
How that it had been established that the 
formation of L.E. cells was due to the presence of 
a factor in the plasma the next step was to identify 
the substance. A few facts were already known con¬ 
cerning its nature. Firstly, it was stable for 
periods of at least as long as six months provided 
that the plasma was kept sterile.~~ It was destroyed 
by heating the plasma to 65° C. Para-aminobenzoic 
acid seemed to inhibit the activity of the factor, 
although this may have been due to a direct effect 
of the acid on the bone marrow. The factor could 
not be detected in patients during a remission but 
only during the acute phase of the disseminated 
lupus erythematosus. The factor could not be found 
in patients suffering from rheumatic fever, subacute 
or chronic lupus erythematosis, cirrhosis, rheumatoid 
arthritis, scleroderma, dermatomyositis, or peri¬ 
arteritis nodosa.Later workers, however, were 
able to demonstrate the L.E. phenomenon in some of 
these conditions and in other diseases as well. 
In order to identify which portion of the blood 
plasma contained the L.E, factor, Haserick, Lewis, 
and Bortz in 19^0, employed fractionation by the 
Tiselius electrophoretic technique.1 These investi¬ 
gators divided plasma from a patient with acute 
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disseminated lupus erythematosis into several 
fractions: 1) albumin, (3.5 mg.); 2) albumin, alpha 
and beta globulin (12 mg.); 3) gamma globulin 
(2 mg.); and 4) gamma globulin and fibrinogen 
(Il.8 rug.). Then, by adding each fraction to normal 
bone marrow and noting L.E. cell formation, it was 
determined that only the gamma globulin fraction 
contained the L.E. factor. 
In an attempt to prove that the L.E. factor is 
an immunologically distinct component of gamma 
globulin, Haserick and Lewis conducted an ingenious 
1 g 
experiment." By electrophoresis they first sepa¬ 
rated the gamma globulin fraction from the plasma 
obtained from a patient suffering with acute dissem¬ 
inated lupus erythematosis. An antiserum against 
this fraction was then produced by repeated in¬ 
jections of the gamma globulin into rabbits. A 
control rabbit antiserum against normal human gamma 
globulin was also produced by the same method. 
Next, the investigators took a quantity of human 
L.E. gamma globulin and divided It into two portions. 
To one portion was added the antiserum to L.E. gamma 
globulin, and to the other was added the control 
antiserum. In both portions a precipitate formed 
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fluid from each portion was then added to bone 
marrow preparations which were subsequently examined 
for L.E. cell formation. The L.E. gamma globulin 
to which had been added the antiserum to normal 
human gamma globulin caused the production of L.E. 
cells. On the other hand, the L.E. gamma globulin 
to which had been added antiserum to L.E. gamma 
globulin was unable to induce L.E. cell formation. 
Although the above experiment has been widely 
accepted as proof that the L.E. factor in gamma 
globulin is a distinct immunological entity, the 
possibility of incomplete precipitation remains as 
an alternative explanation. 
At this point it would be appropriate to list 
the salient properties of the L.E. factor as re¬ 
vealed by past investigations. 
1. The L.E. factor is contained in the 
gamma globulin fraction of the 
blood plasma. 
2. The presence of the factor can be 
demonstrated by adding L.S. plasma 
to a normal bone marrow preparation 
thus producing L.E. cell formation 
(this is referred to as the L.E. 
cell phenomenon). 
. 
. Ic enoiiiir-frvrc'.4 
. . -• . c * . 
. 
. . 
. . . . 
. . 
. . 
. J- - ■ 
. . 




'3 . . 
. 
8. 
3. The L.E. factor is probably a distinct 
immunological entity. 
[f.. The L.E. factor has been found in 
diseases other than acute dissem¬ 
inated lupus erythematosis, notably 
in drug hypersensitivities and in 
some of the other ’’collagen diseases." 
5. The factor induces nucleolysis and 
nucleophagocytosis with the re¬ 
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Methods and Materials 
The Fluorescent Dye Labeled Antibody Technique 
The technique of labeling an antibody with a 
dye so that the complex resulting from the combina¬ 
tion of this labeled antibody with its specific 
antigen could be visualized was first successfully 
17 
accomplished by Reiner in 1930. ' Reiner was able 
to chemically combine antipneumococcus I and II 
antibodies and atoxyl-azo dyes. He noted that the 
dye-antiserum complex had the same agglutinative 
titre as the original antiserum and that its mouse- 
protection activity was unaltered. 
Marrack, in I93J4.J reacted diazotized benzidine- 
azo-R-salt with anti-typhoid and anti-cholera sera 
and then demonstrated that the homologous organisms 
*1 A 
were stained pink by the dye-labeled antibodies." 
In order to prove that the dye-typhoid antibody 
complex was immunologically identical with the 
original typhoid antiserum he performed a rather 
clever experiment. He mixed ordinary cholera anti¬ 
serum with an equal amount of the typhoid antiserum- 
dye complex. To one-half of this mixture he then 
added typhoid bacilli. The cholera vibrios were 
agglutinated but unstained. The typhoid bacilli, 
on the other hand, were not only agglutinated but 
also stained red. This simple procedure demonstrated 
. 
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that the typhoid antiserum was immunologically 
unaltered by the dye conjugation. 
Coons, Creech, and Jones were the first to 
combine an antiserum with a fluorescent moiety and 
thus render the resulting antigen-antibody complex 
fluorescent in ultraviolet light."'1' In I9I1I they 
prepared a B-anthryl-carbamide derivative of anti¬ 
pneumococcus III rabbit serum which produced a. 
faint blue fluorescence in daylight and an intense 
blue fluorescence in ultraviolet light. At the 
same time it was demonstrated that the conjugation 
procedure in no way interfered with the specific 
reactivity of the antiserum. 
In 19I4.2, Coons and his group showed that a 
fluorescein-carbamido-pneumococcal III antiserum 
could specifically stain tissues from a mouse in- 
O r\ 
fected with type III pneumococcus. In 195>0, Coons 
and Kaplan reported improvements in the synthesis 
of fluorescein Isocyanate which had been first 
21 22 
accomplished by Bogert and fright ’ and modified 
later by Coons, Breech, Jones, and Berliner. - At 
the same time they also defined the optimum conditions 
for combining the fluorescent isocyanate dye with 
protein materials. They then conjugated antipneumo- 
coccal rabbit serum, type III, with fluorescein 








isocyanate II by their improved technique. The 
fluorescent dye-labeled antipneumococcal antiserum 
was then successfully used to locate pneumococcal 
2li_ 
polysaccharides in the tissues of mice. ■ 
Many other investigators have employed the 
Coons technique of combining antiserum with the 
fluorescent dye, fluorescein isocyanate, in order 
to locate a specific antigen in animal tissues. 
Conjugates have been prepared to identify the cap- 
sular polysaccharide of Priedlander1s bacillus, 
mumps virus,^ plasma proteins, Endamoeba histo- 
28 
lytica, and many other antigenic substances. 
Figure I is a diagrammatic representation of 
the Coons dye labeled antibody reactions. 
A slightly more complex, but just as useful 
technique is often employed. If, for example, one 
is dealing with an antigen, the antibody to Yfoich 
is located in the gamma globulin fraction of human 
serum it is not necessary to make up a specific 
dye-antibody conjugate against the antigen. Instead, 
a fluorescent antibody is ms.de up against human gamma 
globulin. Then, any antibody from the gamma globulin 
which combines with the antigen will, in turn, also 











a. The antibody with its specific receptor, 1, 




Antibody Dye-antibody conjugate 
(fluorescent) 
b. To identify the specific antigen the dye-antibody 








human gamma globulin. Thus the original antigen 
is labeled by a two stage process (figure II). 
In the work to be reported here, the techniques 
just described were employed In attempts to demon¬ 
strate that a factor in lupus serum is capable of 
combining with some material present in isolated 
chromosomes. 
The Isolation of Chromosomes 
The chromosomes were isolated from chicken 
erythrocytes, which are nucleated. The method 
used was that of Mir sky and Ris.c'; Blood was 
obtained by cutting the chickenTs throat and col¬ 
lecting it in a bottle with oxalate. The blood 
(20 ml.) was then centrifuged for 15> minutes at 
5000 rpm. at a temperature of one degree centigrade. 
The buffy coat and plasma were decanted and the 
remaining red cells washed three times in 0.1 Ip M 
NaCl. Next, the washed cells were mixed with ap¬ 
proximately 100 ml. of O.llp M NaCl, placed In a 
Oaring blendor, and beaten for 20 minutes. Ice 
was packed around the outside of the blendor so 
that the contents could be kept cool. The re¬ 
sulting mixture was centrifuged for minutes at 
. . . ; '• v J ; i - I a '■ 
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a. Antibody with its specific receptor 1, and its 
species specific receptor, 2. 
Antibody A 
b. The antibody against the gamma globulin species 
specific recptor of antibody A is combined with a 




Antibody B Dye-antibody B 
(against gamma globulin) conjugate 
(fluorescent) 
c. To identify the specific antigen, antibody A 
Tnon-fluorescent) is first added. 
iJn + l=L. “ 
Antibody A Specific Antigen Antibody A-antigen 
complex 
d. lext, the dye-antibody B conjugate which is an 
antibody against the species specific receptor of 
antibody A is added. 
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5000 rpin, the red supernatent fluid poured off, 
and the precipitate, consisting of chromosomes 
which have been removed from the erythrocyte nucleus, 
then washed with saline. All solutions were kept 
at approximately one degree centigrade during the 
entire process. 
To verify the presence of chromosomes in the 
precipitate, smears were made on slides and stained 
by the Fuelgen method which is specific for nucleo- 
protein. Chromosomes with their characteristic 
morphology, as described by Mirsky and Ris, could 
26 
be identified. 
Source of Human Sera 
Serum was obtained fom patients who had been 
diagnosed clinically as suffering from lupus erythem¬ 
atosus. The sera used for these tests was known to 
contain the factor, described by Friou, which reacts 
with intact nuclei. Normal serum was also obtained. 
The serum was frozen and stored at minus ten degrees 
centigrade and thawed immediately before use. 
The Fluorescent Antibody* 
Anti-human globulin was produced by repeated 
injection of an alum precipitated gamma globulin 
-«* The fluorescent conjugated antiglobulin was 







into rabbits. The anti-human globulin was then 
separated by ammonium sulfate fractionation from 
the rest of the rabbit serum. Next, the anti-human 
globulin was conjugated with fluorescein isocyanate 
II. The procedure used was that of Coons and Kaplan 
21 
as described in their paper of 1950. The resulting 
fluorescent rabbit anti-human, globulin proved to 
have a precipitin titre of 1:10 against human globu¬ 
lin. 30 
The Staining Procedure 
A drop of the chromosome preparation was placed 
on each of a series of slides. The slides were dried 
at room temperature for ten minutes at a distance 
of three feet from an electric fan. After the drying 
process had been completed, one drop of the thawed 
lupus erythematosiis serum was applied to the dried 
chromosome precipitate on each slide. Next, the 
slides were Incubated for one half hour at room 
temperature. To prevent drying during the incubation 
period these were placed in a covered pan with a 
moist towel in the bottom. The following step was 
a washing procedure using phosphate buffer prepared 
by adding IpO grams of sodium chloride to 6.9 grams 
of sodium phosphate and mixing with enough distilled 











adjusted to 7.0 with I4.O per cent NaOH. 
After the washing has been completed, the 
slides were shaken once or twice to remove any 
excess buffer. One drop of tie fluorescent rabbit 
anti-human globulin conjugate was then applied and 
the slides incubated for one-half hour again, in 
the covered pan. The washing procedure v/as repeated. 
Then, one drop of a glycerine-phosphate buffer 
solution (1 ml. of phosphate buffer plus 9 ml* of 
glycerol) was added to each slide and cover slips 
applied. The slides were now ready to be examined. 
Results 
The chromosomes were seen to readily fluoresce 
under the ultraviolet microscope (plate 1.). This 
suggests that a specific complex has been formed in 
the following sequence: first the chromosomes bind 
a factor in the gamma globulin fraction of the 
lupus erythematosus serum, then the fluorescent 
rabbit anti-human gamma globulin attaches to the 
gamma globulin. The latter combination is known to 
be an antigen-antibody reaction. 
Two controls were run in order to prove that a 
specific combination had taken place between some 











Chromosome stained with fluorescent antibody* 
Due to the printing process the stain appeares blue 






1. ) Normal serum was substituted for the L.E. serum 
in the staining process. No fluorescence was observed, 
2, ) L.E. serum was absorbed with nucleoprotein in 
the following manner: calf thymus nucleoprotein was 
precipitated by adding 170 ml, of .177 M sodium 
chloride solution to 100 ml. of calf thymus nuclear 
extract and refrigerating at kO degrees P. for one- 
half hour. The precipitate was then washed with 
.15 M sodium chloride solution and: centrifuged. 
The absorption was accomplished by adding the nucleo¬ 
protein precipitate to 5 ml. of L.E, serum and 
letting the mixture stand at IpO degrees P. One hour 
later the L.E. serum was decanted and the process 
repeated with another batch of nucleoprotein precip¬ 
itate. It was then determined that the absorbed 
serum did not produce the L.E. phenomenon nor con- 
30 
tain the factor which reacts with intact nuclei. 
When the absorbed lupus serum was used in the 
fluorescent staining process with chromosomes no 
staining took place. This suggests that the material 
in chromosomes with which the lupus globulin factor 
reacts is nucleoprotein. 
The final step in the investigation confirms 











which combines with the lupus serum, factor is indeed 
nucleoprotein, Mir sky and Ris found that chromosomes 
could be fractionated into two parts by placing them 
in a neutral solution of 1 M sodium chloride.^ One 
fraction, the supernatent fluid, proved to be nucleo¬ 
protein. The remaining insoluble precipitate, making 
up 8 to 10 per cent of the chromosomal mass contained, 
!l12 to lip per cent ribose nucleic and about one-fifth 
m2Q 
as much desoxyribose nucleic acid. 7 Following the 
method of Mirsky and Ris, the chicken erythrocyte 
chromosomes were fractionated. The supernatant fluid, 
virtually pure nucleoprotein, was dried on a slide 
and stained by the fluorescent antibody technique 








By use of Coons’ fluorescent antibody staining 
technique, it was demonstrated that a serum factor 
from patients with lupus erythematosus adheres to 
isolated chromosomes. It was further shown that 
this is due to a combination between the nucleo- 
protein of the chromosomes and the factor of the 
serum 
■■■■3' ' : • : 
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